Efalizumab binding to the LFA-1 alpha(L) I domain blocks ICAM-1 binding via steric hindrance
文献类型：期刊论文
| 作者 | Li, S; Wang, H; Peng, BZ; Zhang, ML; Zhang, DP; Hou, S; Guo, YJ; Ding, JP |
| 刊名 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
 |
| 出版日期 | 2009 |
| 卷号 | 106期号:11页码:4349-4354 |
| 通讯作者 | Guo, YJ (reprint author), Second Mil Med Univ, Int Joint Canc Inst, 800 Xiang Yin Rd, Shanghai 200433, Peoples R China.,yjguo@smmu.edu.cn ; jpding@sibs.ac.cn |
| 英文摘要 | Lymphocyte function-associated antigen 1 (LFA-1) plays important roles in immune cell adhesion, trafficking, and activation and is a therapeutic target for the treatment of multiple autoimmune diseases. Efalizumab is one of the most efficacious antibody drugs for treating psoriasis, a very common skin disease, through inhibition of the binding of LFA-1 to the ligand intercellular adhesion molecule 1 (ICAM-1). We report here the crystal structures of the Efalizumab Fab alone and in complex with the LFA-1 alpha(L) I domain, which reveal the molecular mechanism of inhibition of LFA-1 by Efalizumab. The Fab binds with an epitope on the inserted (I) domain that is distinct from the ligand-binding site. Efalizumab binding blocks the binding of LFA-1 to ICAM-1 via steric hindrance between its light chain and ICAM-1 domain 2 and thus inhibits the activities of LFA-1. These results have important implications for the development of improved antibodies and new therapeutic strategies for the treatment of autoimmune diseases. |
| 学科主题 | Science & Technology - Other Topics |
| 类目[WOS] | Multidisciplinary Sciences |
| 关键词[WOS] | FUNCTION-ASSOCIATED ANTIGEN-1 ; INTERCELLULAR-ADHESION MOLECULE-1 ; CRYSTAL-STRUCTURE ; STRUCTURAL BASIS ; MONOCLONAL-ANTIBODIES ; INTEGRIN REGULATION ; LEUKOCYTE ADHESION ; INSERTED DOMAIN ; A-DOMAIN ; CD11A |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000264278800054 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/1259]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Li, S,Wang, H,Peng, BZ,et al. Efalizumab binding to the LFA-1 alpha(L) I domain blocks ICAM-1 binding via steric hindrance[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,2009,106(11):4349-4354. |
| APA | Li, S.,Wang, H.,Peng, BZ.,Zhang, ML.,Zhang, DP.,...&Ding, JP.(2009).Efalizumab binding to the LFA-1 alpha(L) I domain blocks ICAM-1 binding via steric hindrance.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,106(11),4349-4354. |
| MLA | Li, S,et al."Efalizumab binding to the LFA-1 alpha(L) I domain blocks ICAM-1 binding via steric hindrance".PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 106.11(2009):4349-4354. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。